News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Immutep bounces off decade-long lows thanks to cash from GSK
News
Rise & Shine: What you need to know before the ASX opens
News
Weed Week: American pot could be worth $60 billion by 2025
News
Weekly small cap wrap: Who deserves a high five?
News
Weed Week: US looks at ways to help cannabis players get banking access
Health & Biotech
Rhinomed will explore links between poor sleep and suicide in new study
Health & Biotech
Health: Neuren’s secondary drug shows more efficacy in mice, shares rise 50pc
Health & Biotech
Rhinomed breathing easy thanks to strong March quarter, shares rise 26pc
News
Quarterlies: Marley Spoon is spending now to profit later, aims to break even by 2020
Health & Biotech
Kim Kardashian is having a CBD baby shower. Has cannabis peaked?
Health & Biotech
Two medical device smallcaps are up, one is down after a soft quarterly
Health & Biotech
Weed week: wtf happened with MMJ?
Health & Biotech
Weed week: here’s all the news driving ASX cannabis stocks
Health & Biotech
Weed week: it’s reefer madness as global pot stocks pass $6b in fund raising
Health & Biotech
These seven ASX-listed pot stocks are hoping for a US high
Health & Biotech
Rhinomed does US deal to put cannabis up your nose
Health & Biotech
